The bad news keeps on creeping toward Vyne Therapeutics’ BET inhibitor platform. Weeks after the biotech gave up on a psoriasis trial of one drug that was lumbered with a partial clinical hold, the ...
Elon Musk will bring back the defunct short-video platform Vine — only this time with an artificial intelligence twist that could transform how users create and share content online. The tech ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback